Deal Watch: Merck Decides Better Late Than Never In GLP-1 Deal With Hansoh
Plus deals involving Novartis/BioAge, Novo Nordisk/Photys, Tvardi/Cara, Gilead/Terray, Candid/Ab Studio/EpimAb/Nona, AbbVie/Nimble and more.
Plus deals involving Novartis/BioAge, Novo Nordisk/Photys, Tvardi/Cara, Gilead/Terray, Candid/Ab Studio/EpimAb/Nona, AbbVie/Nimble and more.